Incremental

Making Psychedelic-Assisted Therapy (P-AT) available to everyone
In the not-too-distant future, you will be able to experience P-AT in a safe and comfortable facility where you live.   
How? It’s an Incremental process. Here are the steps:
For everyone to afford it, P-AT must be covered by insurance
For insurance to cover it, P-AT must be approved by the FDA
To gain FDA approval, P-AT must be proven safe and effective in Randomized, Controlled Trials (RCTs)
For RCTs to be conducted, a nationwide network of research sites must be created and maintained
>45k
Vetted UK patient databas
6
Investigators with experience in 20+ indications
15
Psychiatric conditions we’ve worked with
>1k
Therapist database
>45k
Vetted UK patient databas
6
Investigators with experience in 20+ indications
15
Psychiatric conditions we’ve worked with
>1k
Therapist database
>45k
Vetted UK patient databas
6
Investigators with experience in 20+ indications
15
Psychiatric conditions we’ve worked with
>1k
Therapist database
We’re currently on the first step: building a network of sites in which the RCTs can be conducted. Helping with this phase is where Incremental is focused.

We help Sponsors (Companies developing P-AT treatments) connect with the sites they need to conduct research, and we help existing Interventional Psychiatry clinics become RCT sites, conducting research for Sponsors.
>45k
Vetted UK patient databas
6
Investigators with experience in 20+ indications
15
Psychiatric conditions we’ve worked with
>1k
Therapist database
Every day we take another incremental step toward building a world where everyone has the option to do P-AT.
To make this vision reality, we all have to contribute. Join us! Let’s build this world together. Building this new world is fun and it is worth the effort.
“I’d like to express my huge appreciation to the whole Clerkenwell Health team. I felt very safe and looked after by everyone there. I can’t express enough how this trial changed my life and I am thankful that I have been a part of it.”
Trial participant '23
“We have been working with the Clerkenwell team for almost a year and have found their expertise in psychedelics and the specific requirements of them regarding trial design to be a great asset and a rare find in a CRO. "
CEO, Mindset
"Everyone that I had the pleasure of meeting / interacting with was nothing short of exceptional. I always felt at ease and in safe company. Outstanding."
Trial participant '23
– As seen in –